Down-regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Enhances Gensenoside Rh2 Pharmacological Action on Leukemia KG1α Cells |
You, Zhi-Mei
(Laboratory of Stem Cells and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University)
Zhao, Liang (Laboratory of Stem Cells and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University) Xia, Jing (Laboratory of Stem Cells and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University) Wei, Qiang (Laboratory of Stem Cells and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University) Liu, Yu-Min (College of Pharmacy, the First Affiliated Hospital, Chongqing Medical University) Liu, Xiao-Yan (Department of Geriatrics, the First Affiliated Hospital, Chongqing Medical University) Chen, Di-Long (Laboratory of Stem Cells and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University) Li, Jing (Laboratory of Stem Cells and Tissue Engineering, Department of Histology and Embryology, Chongqing Medical University) |
1 | Zhang C, Yu H, Hou J (2011). Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells. Zhongguo Zhong Yao Za Zhi, 36, 1670-4. |
2 | Guarino M (2007). Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell bio, 39, 2153-60. DOI ScienceOn |
3 | Wang W, Wang H, Rayburn ER, et al (2008). 20 (S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action. Br J Cancer, 98, 792-802. DOI ScienceOn |
4 | Tsutsumi S, Hogan V, Nabi IR, et al (2003). Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. Cancer Res, 63, 242-9. |
5 | Tsutsumi S, Yanagawa T, Shimura T, et al (2003). Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling. J Biol Chem, 278, 32165-72. DOI ScienceOn |
6 | Vander Haar E, Lee SI, Bandhakavi S, et al (2007). Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol, 9, 316-23. DOI ScienceOn |
7 | Wang Z, Zheng Q, Liu K, et al (2006). Ginsenoside Rh (2) enhances antitumour activity and decreases genotoxic effect of cyclophosphamide. Basic Clin Pharmacol Toxicol, 98, 411-5. DOI ScienceOn |
8 | Wullschleger S, Loewith R, Hall MN (2006). TOR signaling in growth and metabolism. Cell, 124, 471-84. DOI ScienceOn |
9 | Xu W, Seiter K, Feldman E, et al (1996). The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. Blood, 87, 4502-6. |
10 | Yakirevich E, Naot Y (2000). Cloning of a glucose phosphate isomerase/neuroleukin-like sperm antigen involved in sperm agglutination. Biol Reprod, 62, 1016-23. DOI ScienceOn |
11 | Yanagawa T, Funasaka T, Tsutsumi S, et al (2004). Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy. Endocr Relat Cancer, 11, 749-59. DOI ScienceOn |
12 | Niinaka Y, Harada K, Fujimuro M, et al (2010). Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis. Cancer Res, 70, 9483-93. DOI |
13 | Matsumoto I, Staub A, Benoist C, et al (1999). Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science, 286, 1732-5. DOI ScienceOn |
14 | Nicholson KM, Anderson NG (2002). The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal, 14, 381-95. DOI ScienceOn |
15 | Park EK, Lee EJ, Lee SH, et al (2010). Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of Akt. Br J Pharmacol, 160, 1212-23. DOI ScienceOn |
16 | Park HM, Kim SJ, Kim JS, et al (2012). Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways. Food Chem Toxicol, 50, 2736-41. DOI ScienceOn |
17 | Sancak Y, Thoreen CC, Peterson TR, et al, (2007). PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell, 25, 903-15. DOI ScienceOn |
18 | Shih WL, Yu FL, Chang CD, et al (2012). Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model. Mol Carcinog, 52, 800-12 |
19 | Thiery JP, Sleeman JP (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol, 7, 131-42. DOI ScienceOn |
20 | Tang XP, Tang GD, Fang CY, et al (2013). Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. World J Gastroenterol, 19, 1582-92. DOI ScienceOn |
21 | Gwinn DM, Shackelford DB, Egan DF, et al (2008). AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell, 30, 214-26. DOI ScienceOn |
22 | Funasaka T, Hu H, Hogan V, et al (2007). Down-regulation of phosphoglucose isomerase/autocrine motility factor expression sensitizes human fibrosarcoma cells to oxidative stress leading to cellular senescence. Journal Chem, 282, 36362-9. |
23 | Funasaka T, Hu H, Yanagawa T, et al (2007). Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells. Cancer Res, 67, 4236-43. DOI ScienceOn |
24 | Gingras AC, Raught B, Sonenberg N (2001). Regulation of translation initiation by FRAP/mTOR. Genes Dev, 15, 807-26. DOI ScienceOn |
25 | Haga A, Funasaka T, Niinaka Y, et al (2003). Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expression. International journal of cancer. Int J Cancer, 107, 707-14. DOI ScienceOn |
26 | Helms S (2004). Cancer prevention and therapeutics: Panax ginseng. Alter Med Rev, 9, 259-74. |
27 | Huang S, Houghton PJ (2003). Targeting mTOR signaling for cancer therapy. Cur Opin Pharmacol, 3, 371-7. DOI ScienceOn |
28 | Kho DH, Nangia-Makker P, Balan V, et al (2013). Autocrine motility factor promotes HER2 cleavage and signaling in breast cancer cells. Cancer Res, 73, 1411-9. DOI |
29 | Lee JM, Dedhar S, Kalluri R, et al (2006). The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol, 172, 973-81. DOI ScienceOn |
30 | Kovacina KS, Park GY, Bae SS, et al (2003). Identification of a proline-rich Akt substrate as a 14-3-3 binding partner. J Biol Chem, 278, 10189-94. DOI ScienceOn |
31 | Cao MJ, Osatomi K, Matsuda R, et al (2000). Purification of a novel serine proteinase inhibitor from the skeletal muscle of white croaker (Argyrosomus argentatus). Biochem Biophys Res Commun, 272, 485-89. DOI ScienceOn |
32 | Cheng CC, Yang SM, Huang CY, et al (2005). Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother Pharmacol, 55, 531-40. DOI ScienceOn |
33 | Christensen, LP (2009). Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutrition Res, 55, 1-99. |
34 | Chung KS, Cho SH, Shin JS, et al (2013). Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-beta expression. Carcinogenesis, 34, 331-40. DOI ScienceOn |
35 | Dennis PB, Jaeschke A, Saitoh M, et al (2001). Mammalian TOR: a homeostatic ATP sensor. Science, 294, 1102-5. DOI ScienceOn |
36 | Fu M, Li L, Albrecht T, et al (2011). Autocrine motility factor/phosphoglucose isomerase regulates ER stress and cell death through control of ER calcium release. Cell Death Differ, 18, 1057-70. DOI ScienceOn |
37 | Funasaka T, Hogan V, Raz A (2009). Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer. Cancer Res, 69, 5349-56. DOI ScienceOn |
38 | Li B, Zhao J, Wang CZ, et al (2011). Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer lett, 301, 185-92. DOI ScienceOn |